AXVIX
Price
$19.94
Change
+$1.21 (+6.46%)
Updated
Feb 3 closing price
Net Assets
30.96M
VSCAX
Price
$28.51
Change
+$2.43 (+9.32%)
Updated
Feb 3 closing price
Net Assets
9.42B
Interact to see
Advertisement

AXVIX vs VSCAX

Header iconAXVIX vs VSCAX Comparison
Open Charts AXVIX vs VSCAXBanner chart's image
Acclivity Small Cap Value I
Price$19.94
Change+$1.21 (+6.46%)
VolumeN/A
Net Assets30.96M
Invesco Small Cap Value A
Price$28.51
Change+$2.43 (+9.32%)
VolumeN/A
Net Assets9.42B
AXVIX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
VS
AXVIX vs. VSCAX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXVIX is a Buy and VSCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 9.42B vs. AXVIX (31M). AXVIX pays higher dividends than VSCAX: AXVIX (1.66) vs VSCAX (0.23). AXVIX was incepted earlier than VSCAX: AXVIX (7 years) vs VSCAX (27 years). VSCAX (1.10) is less costly to investors than AXVIX (1.04). AXVIX is a more actively managed with annual turnover of: 96.00 vs. VSCAX (52.00). VSCAX has a lower initial minimum investment than AXVIX: VSCAX (1000) vs AXVIX (20000). VSCAX annual gain was more profitable for investors over the last year : 18.26 vs. AXVIX (8.95). VSCAX return over 5 years is better than : 68.92 vs. AXVIX (53.34).
AXVIXVSCAXAXVIX / VSCAX
Total Expense Ratio0.481.1044%
Annual Report Gross Expense Ratio1.041.1095%
Fund Existence7 years27 years-
Gain YTD7.26212.64357%
Front LoadN/A6%-
Min. Initial Investment2000010002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets31M9.42B0%
Annual Yield % from dividends1.660.23717%
Returns for 1 year8.9518.2649%
Returns for 3 years19.4651.2738%
Returns for 5 years53.3468.9277%
Returns for 10 yearsN/A108.32-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEV780.2525.28
+3.35%
GE Vernova
ANAB51.210.67
+1.33%
AnaptysBio
JMSB20.990.06
+0.29%
John Marshall Bancorp
ATRA5.04N/A
N/A
Atara Biotherapeutics Inc.
DOCS34.85-2.44
-6.54%
Doximity